Ignite Creation Date:
2024-05-05 @ 11:43 PM
Last Modification Date:
2024-10-26 @ 10:39 AM
Study NCT ID:
NCT01407822
Status:
UNKNOWN
Last Update Posted:
2018-09-11
First Post:
2011-07-26
Brief Title:
Erlotinib Versus GemcitabineCisplatin as NeoAdjuvant Treatment in Non-small Cell Lung Cancer
Sponsor:
Guangdong Association of Clinical Trials
Organization:
Guangdong Association of Clinical Trials